A.D.A.M. has been admitted to the highly coveted Creative Destruction Lab (CDL) Program held in Berlin, Germany.
This inclusion marks a major milestone for A.D.A.M. and solidifies its position as a pioneering force in the 3D bioprinting industry. The Creative Destruction Lab is a prestigious global venture lab that supports the development and commercialization of groundbreaking technologies. The CDL Berlin Program specifically focuses on fostering start-ups in Europe, providing them with access to world-class mentorship, capital networks, and top-tier investors.
By joining the CDL Berlin Program, A.D.A.M. will gain access to invaluable resources and network with leading experts, mentors, and industry veterans.
The Creative Destruction Lab Berlin Program is renowned for its rigorous selection process and stringent evaluation criteria. The program only admits companies with groundbreaking technologies that display exceptional potential for commercialization and global impact. Being accepted into this highly competitive program demonstrates A.D.A.M.'s commitment to driving innovation in the bioprinting industry and its ability to transform healthcare as we know it.
"We are thrilled to join the Creative Destruction Lab Berlin Program", said CEO, Denys Gurak. "This is a testament to the extraordinary potential of our 3D bioprinting technology and the remarkable impact it can have on the future of healthcare. We look forward to working closely with CDL mentors and leveraging their expertise to bring our vision to fruition. As we are working on our pilot point-of-care facility in Poland, the access to a wider European network fits well with A.D.A.M.’s strategy".
This inclusion marks a major milestone for A.D.A.M. and solidifies its position as a pioneering force in the 3D bioprinting industry. The Creative Destruction Lab is a prestigious global venture lab that supports the development and commercialization of groundbreaking technologies. The CDL Berlin Program specifically focuses on fostering start-ups in Europe, providing them with access to world-class mentorship, capital networks, and top-tier investors.
By joining the CDL Berlin Program, A.D.A.M. will gain access to invaluable resources and network with leading experts, mentors, and industry veterans.
The Creative Destruction Lab Berlin Program is renowned for its rigorous selection process and stringent evaluation criteria. The program only admits companies with groundbreaking technologies that display exceptional potential for commercialization and global impact. Being accepted into this highly competitive program demonstrates A.D.A.M.'s commitment to driving innovation in the bioprinting industry and its ability to transform healthcare as we know it.
"We are thrilled to join the Creative Destruction Lab Berlin Program", said CEO, Denys Gurak. "This is a testament to the extraordinary potential of our 3D bioprinting technology and the remarkable impact it can have on the future of healthcare. We look forward to working closely with CDL mentors and leveraging their expertise to bring our vision to fruition. As we are working on our pilot point-of-care facility in Poland, the access to a wider European network fits well with A.D.A.M.’s strategy".